Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

1.

Review article: the efficacy of biomarkers in chronic fibroproliferative diseases - early diagnosis and prognosis, with liver fibrosis as an exemplar.

Karsdal MA, Krarup H, Sand JM, Christensen PB, Gerstoft J, Leeming DJ, Weis N, Schaffalitzky de Muckadell OB, Krag A.

Aliment Pharmacol Ther. 2014 Aug;40(3):233-49. doi: 10.1111/apt.12820. Epub 2014 Jun 9.

PMID:
24909260
[PubMed - in process]
2.

Strategies to manage hepatitis C virus (HCV) disease burden.

Wedemeyer H, Duberg AS, Buti M, Rosenberg WM, Frankova S, Esmat G, Örmeci N, Van Vlierberghe H, Gschwantler M, Akarca U, Aleman S, Balık I, Berg T, Bihl F, Bilodeau M, Blasco AJ, Brandão Mello CE, Bruggmann P, Calinas F, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, Cornberg M, Cramp ME, Dore GJ, Doss W, El-Sayed MH, Ergör G, Estes C, Falconer K, Félix J, Ferraz ML, Ferreira PR, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL Jr, Guimarães Pessôa M, Hézode C, Hindman SJ, Hofer H, Husa P, Idilman R, Kåberg M, Kaita KD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marinho RT, Marotta P, Mauss S, Mendes Correa MC, Moreno C, Müllhaupt B, Myers RP, Nemecek V, Øvrehus AL, Parkes J, Peltekian KM, Ramji A, Razavi H, Reis N, Roberts SK, Roudot-Thoraval F, Ryder SD, Sarmento-Castro R, Sarrazin C, Semela D, Sherman M, Shiha GE, Sperl J, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, Van Damme P, van Thiel I, Vandijck D, Vogel W, Waked I, Weis N, Wiegand J, Yosry A, Zekry A, Negro F, Sievert W, Gower E.

J Viral Hepat. 2014 May;21 Suppl 1:60-89. doi: 10.1111/jvh.12249.

PMID:
24713006
[PubMed - in process]
3.

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.

Razavi H, Waked I, Sarrazin C, Myers RP, Idilman R, Calinas F, Vogel W, Mendes Correa MC, Hézode C, Lázaro P, Akarca U, Aleman S, Balık I, Berg T, Bihl F, Bilodeau M, Blasco AJ, Brandão Mello CE, Bruggmann P, Buti M, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, Cramp ME, Dore GJ, Doss W, Duberg AS, El-Sayed MH, Ergör G, Esmat G, Falconer K, Félix J, Ferraz ML, Ferreira PR, Frankova S, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL Jr, Gower E, Gschwantler M, Guimarães Pessôa M, Hindman SJ, Hofer H, Husa P, Kåberg M, Kaita KD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Marinho RT, Marotta P, Mauss S, Moreno C, Murphy K, Negro F, Nemecek V, Örmeci N, Øvrehus AL, Parkes J, Pasini K, Peltekian KM, Ramji A, Reis N, Roberts SK, Rosenberg WM, Roudot-Thoraval F, Ryder SD, Sarmento-Castro R, Semela D, Sherman M, Shiha GE, Sievert W, Sperl J, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, Van Damme P, van Thiel I, Van Vlierberghe H, Vandijck D, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Cornberg M, Müllhaupt B, Estes C.

J Viral Hepat. 2014 May;21 Suppl 1:34-59. doi: 10.1111/jvh.12248.

PMID:
24713005
[PubMed - in process]
4.

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

Bruggmann P, Berg T, Øvrehus AL, Moreno C, Brandão Mello CE, Roudot-Thoraval F, Marinho RT, Sherman M, Ryder SD, Sperl J, Akarca U, Balık I, Bihl F, Bilodeau M, Blasco AJ, Buti M, Calinas F, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, Cornberg M, Cramp ME, Dore GJ, Doss W, Duberg AS, El-Sayed MH, Ergör G, Esmat G, Estes C, Falconer K, Félix J, Ferraz ML, Ferreira PR, Frankova S, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL Jr, Gower E, Gschwantler M, Guimarães Pessôa M, Hézode C, Hofer H, Husa P, Idilman R, Kåberg M, Kaita KD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marotta P, Mauss S, Mendes Correa MC, Müllhaupt B, Myers RP, Negro F, Nemecek V, Örmeci N, Parkes J, Peltekian KM, Ramji A, Razavi H, Reis N, Roberts SK, Rosenberg WM, Sarmento-Castro R, Sarrazin C, Semela D, Shiha GE, Sievert W, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, van Thiel I, Van Vlierberghe H, Vandijck D, Vogel W, Waked I, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Van Damme P, Aleman S, Hindman SJ.

J Viral Hepat. 2014 May;21 Suppl 1:5-33. doi: 10.1111/jvh.12247.

PMID:
24713004
[PubMed - in process]
5.

Increased prevalence of coronary artery disease risk markers in patients with chronic hepatitis C--a cross-sectional study.

Roed T, Kristoffersen US, Knudsen A, Wiinberg N, Lebech AM, Almdal T, Thomsen RW, Kjær A, Weis N.

Vasc Health Risk Manag. 2014 Jan 21;10:55-62. doi: 10.2147/VHRM.S53557. eCollection 2014.

PMID:
24482574
[PubMed - in process]
Free PMC Article
6.

Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study.

Andersen ES, Rødgaard-Hansen S, Moessner B, Christensen PB, Møller HJ, Weis N.

Eur J Clin Microbiol Infect Dis. 2014 Jan;33(1):117-22. doi: 10.1007/s10096-013-1936-3. Epub 2013 Aug 10.

PMID:
24424890
[PubMed - in process]
7.

Hepatitis B prevalence in Denmark - an estimate based on nationwide registers and a national screening programme, as on 31 December 2007.

Hansen N, Hay G, Cowan S, Jepsen P, Bygum Krarup H, Obel N, Weis N, Brehm Christensen P.

Euro Surveill. 2013 Nov 21;18(47). pii: 20637.

PMID:
24300884
[PubMed - indexed for MEDLINE]
Free Article
8.

Genetic variation in toll-like receptors and retinoic acid-inducible gene I and outcome of hepatitis C virus infection: a candidate gene association study.

Clausen LN, Ladelund S, Weis N, Bukh J, Benfield T.

J Viral Hepat. 2014 Aug;21(8):578-84. doi: 10.1111/jvh.12188. Epub 2013 Nov 13.

PMID:
24224717
[PubMed - in process]
9.

Apoptotic cells enhance sphingosine-1-phosphate receptor 1 dependent macrophage migration.

Weichand B, Weis N, Weigert A, Grossmann N, Levkau B, Brüne B.

Eur J Immunol. 2013 Dec;43(12):3306-13. doi: 10.1002/eji.201343441. Epub 2013 Aug 29.

PMID:
23934754
[PubMed - indexed for MEDLINE]
10.

Socioeconomic status in HCV infected patients - risk and prognosis.

Omland LH, Osler M, Jepsen P, Krarup H, Weis N, Christensen PB, Roed C, Sørensen HT, Obel N.

Clin Epidemiol. 2013 May 31;5:163-72. doi: 10.2147/CLEP.S43926. Print 2013.

PMID:
23766659
[PubMed]
Free PMC Article
11.

Neutralization resistance of hepatitis C virus can be overcome by recombinant human monoclonal antibodies.

Pedersen J, Carlsen TH, Prentoe J, Ramirez S, Jensen TB, Forns X, Alter H, Foung SK, Law M, Gottwein J, Weis N, Bukh J.

Hepatology. 2013 Nov;58(5):1587-97. doi: 10.1002/hep.26524. Epub 2013 Aug 7.

PMID:
23729237
[PubMed - indexed for MEDLINE]
12.

Neutralizing antibodies in patients with chronic hepatitis C, genotype 1, against a panel of genotype 1 culture viruses: lack of correlation to treatment outcome.

Pedersen J, Jensen TB, Carlsen TH, Schønning K, Christensen PB, Laursen AL, Krarup H, Bukh J, Weis N.

PLoS One. 2013 May 7;8(5):e62674. doi: 10.1371/journal.pone.0062674. Print 2013.

PMID:
23667506
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

[The Danish Database for Hepatitis B and C].

Weis N, Thomsen RW; DANHEP-styregruppen.

Ugeskr Laeger. 2012 Oct 15;174(42):2521. Danish. No abstract available.

PMID:
23079424
[PubMed - indexed for MEDLINE]
14.

Hepatitis C virus infection and risk of coronary artery disease: a systematic review of the literature.

Roed T, Lebech AM, Kjaer A, Weis N.

Clin Physiol Funct Imaging. 2012 Nov;32(6):421-30. doi: 10.1111/j.1475-097X.2012.01152.x. Epub 2012 Jul 30. Review.

PMID:
23031062
[PubMed - indexed for MEDLINE]
15.

IP-10 can be measured in dried plasma spots in patients with chronic hepatitis C infection.

Ruhwald M, Andersen ES, Christensen PB, Moessner BK, Weis N.

PLoS One. 2012;7(9):e45181. Epub 2012 Sep 14.

PMID:
23024806
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Hepatitis C prevalence in Denmark -an estimate based on multiple national registers.

Christensen PB, Hay G, Jepsen P, Omland LH, Just SA, Krarup HB, Weis N, Obel N, Cowan S.

BMC Infect Dis. 2012 Aug 6;12:178.

PMID:
22866925
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Treatment for hepatitis B virus (HBV) and hepatitis C virus (HCV) infection - Danish national guidelines 2011.

Christensen PB, Clausen MR, Krarup H, Laursen AL, Schlichting P, Weis N; Danish Society of Infectious Diseases; Danish Society of Gastroenterology and Hepatology.

Dan Med J. 2012 Jun;59(6):C4465.

PMID:
22677253
[PubMed - indexed for MEDLINE]
18.

Loss of the ceramide transfer protein augments EGF receptor signaling in breast cancer.

Heering J, Weis N, Holeiter M, Neugart F, Staebler A, Fehm TN, Bischoff A, Schiller J, Duss S, Schmid S, Korte T, Herrmann A, Olayioye MA.

Cancer Res. 2012 Jun 1;72(11):2855-66. doi: 10.1158/0008-5472.CAN-11-3069. Epub 2012 Apr 3.

PMID:
22472120
[PubMed - indexed for MEDLINE]
Free Article
19.

Major differences in assisted reproductive treatments offered to HIV-1 infected patients in the Nordic countries.

Wessman M, Westling K, Aho I, Quist-Paulsen E, Wæhre T, Rolfhamre L, Weis N, Katzenstein TL.

Scand J Infect Dis. 2012 May;44(5):402-4. doi: 10.3109/00365548.2011.649491. Epub 2012 Jan 31. No abstract available.

PMID:
22292615
[PubMed - indexed for MEDLINE]
20.

Sphingosine-1-phosphate signalling induces the production of Lcn-2 by macrophages to promote kidney regeneration.

Sola A, Weigert A, Jung M, Vinuesa E, Brecht K, Weis N, Brüne B, Borregaard N, Hotter G.

J Pathol. 2011 Dec;225(4):597-608. doi: 10.1002/path.2982.

PMID:
22025214
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk